Table 1. Detection frequencies of HPgV-2 in different populations in Guangdong and Sichuan Provinces, China*.
| Province, group, and subgroup |
No. tested |
HPgV-2 |
HPgV RNA+, no. (%) |
|
|---|---|---|---|---|
| Ab+, no. (%) |
RNA+, no. (%) |
|||
| Guangdong Province | ||||
| HCV-infected patients | ||||
| Ab+/RNA+ | 57 | 1 (1.8) | 1(1.8) | 8 (14.0) |
| Ab–/RNA+ | 7 | 0 | 0 | 0 |
| Ab+/RNA– | 22 | 0 | 0 | 4 (18.2) |
| Total | 86 | 1 (1.2) | 1 (1.2) | 12 (14.0) |
| PWID | ||||
| HIV-1+/HCV Ab+/RNA+ | 70 | 9 (12.9) | 4 (5.7) | 28 (40.0) |
| MSM | ||||
| HIV-1+/HCV+ | 12 | 1 (8.3) | 0 | 4 (33.3) |
| HIV-1+/HCV– | 100 | 0 | 0 | 28 (28.0) |
| HIV-1–/HCV+ | 10 | 0 | 0 | 1 (10.0) |
| HIV-1–/HCV– | 89 | 0 | 0 | 7 (7.9) |
| Total | 211 | 1 (0.5) | 0 | 40 (19.0) |
| Blood donors | ||||
| HIV-1–/HCV–/HBV– | 500 | 2 (0.4) | 0 | NT |
| HCV Ab+/HCV RNA+ | 2 | 2 | 2 | NT |
| Sichuan Province | ||||
|---|---|---|---|---|
| PWID | ||||
| HIV-1+/HCV Ab+ | 270 | 43 (15.9) | 8 (3.0) | NT |
*Ab, antibodies; HBV, hepatitis B virus; HCV, hepatitis C virus; HPgV, human pegivirus; HPgV-2, second human pegivirus; MSM, men who have sex with men; NT, not tested; PWID, people who inject drugs; +, positive; –, negative.